DNA adducts in humans as dosimeters of exposure to environmental, occupational, or dietary genotoxins 1

The quantitation of adducts of genotoxins with DNA is probably one of the best indicators of genetic damage due to exposure to toxins or carcinogens. It is generally believed that such adducts can lead to mutations, which in turn can trigger the initiation of the carcinogenic process. DNA adducts have been quantitated in white blood cells and in various tissues of smokers, persons in certain high‐exposure occupations, and persons consuming foods contaminated with certain carcinogens. The feasibility of this approach for biochemical epidemiologic studies has been demonstrated using methods such as 32P‐postlabeling, enzyme‐linked immunosorbent assay, and synchronous fluorescence spectrophotometry. Relatively large interindividual differences in DNA adducts have been observed in both exposed and nonexposed persons. As a result, there are only a few studies in which clear quantitative and qualitative differences between these two groups have been observed. In addition, it appears that in some studies the 32P‐postlabeling method does not detect the presence of the polycyclic aromatic hydrocarbon DNA adducts that are detectable by immunoassays. More extensive studies in additional populations at risk should shed further light on the utility of DNA adduct analysis in biochemical monitoring, especially if further refinements in methodology would result in increased sensitivity and specificity.— Schut, H. A. J.; Shiverick, K. T. DNA adducts in humans as dosimeters of exposure to environmental, occupational, or dietary genotoxins. FASEB J. 6: 2942‐2951; 1992.

[1]  C. Angeletti,et al.  Comparison of pulmonary DNA adduct levels, measured by 32P-postlabelling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokers. , 1991, Carcinogenesis.

[2]  T. A. Avitts,et al.  Detection of smoking-related covalent DNA adducts in human placenta. , 1986, Science.

[3]  N. van Zandwijk,et al.  Polycyclic aromatic hydrocarbon-DNA adducts in lung tissue from lung cancer patients. , 1990, Carcinogenesis.

[4]  D. Phillips,et al.  Smoking and DNA damage in cervical cells , 1990, The Lancet.

[5]  S. Venitt,et al.  DNA adducts, detected by 32P-postlabelling, in the foregut of patients with familial adenomatous polyposis and in unaffected controls. , 1991, Carcinogenesis.

[6]  J. Cuzick,et al.  DNA adducts in different tissues of smokers and non‐smokers , 1990, International journal of cancer.

[7]  C. Harris,et al.  Determination of polycyclic aromatic hydrocarbons in the urine, benzo(a)pyrene diol epoxide-DNA adducts in lymphocyte DNA, and antibodies to the adducts in sera from coke oven workers exposed to measured amounts of polycyclic aromatic hydrocarbons in the work atmosphere. , 1986, Cancer research.

[8]  T. A. Avitts,et al.  Comparative 32P-analysis of cigarette smoke-induced DNA damage in human tissues and mouse skin. , 1986, Cancer research.

[9]  R. Doll,et al.  The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. , 1981, Journal of the National Cancer Institute.

[10]  R. C. Garner,et al.  Immunoassay procedures to detect exposure to aflatoxin B1 and benzo(a)pyrene in animals and man at the DNA level , 1988, International archives of occupational and environmental health.

[11]  T. A. Avitts,et al.  Quantitative associations between DNA damage in human placenta and maternal smoking and birth weight. , 1988, Journal of the National Cancer Institute.

[12]  R. Gupta,et al.  Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts. , 1985, Cancer research.

[13]  T. A. Avitts,et al.  Covalent DNA damage in tissues of cigarette smokers as determined by 32P-postlabeling assay. , 1989, Journal of the National Cancer Institute.

[14]  D. Phillips,et al.  32P-postlabelling detection of aromatic DNA adducts in peripheral blood lymphocytes from aluminium production plant workers. , 1991, Mutation research.

[15]  C. Wild,et al.  06‐Methyldeoxyguanosine in oesophageal dna among individuals at high risk of oesophageal cancer , 1985 .

[16]  D. Warburton,et al.  Polycyclic aromatic hydrocarbon-DNA adducts in spontaneously aborted fetal tissue. , 1990, Carcinogenesis.

[17]  F. Perera,et al.  DNA adducts in human environmentally exposed to aromatic compounds in an industrial area of Poland. , 1990, Carcinogenesis.

[18]  F. Perera,et al.  Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells of foundry workers. , 1988, Cancer research.

[19]  R. Santella DNA adducts in humans as biomarkers of exposure to environmental and occupational carcinogens , 1991 .

[20]  K. Hemminki,et al.  DNA adducts in lymphocytes and granulocytes of smokers and nonsmokers detected by the 32P-postlabelling assay. , 1991, Carcinogenesis.

[21]  F. V. van Schooten,et al.  Determination of benzo[a]pyrene diol epoxide-DNA adducts in white blood cell DNA from coke-oven workers: the impact of smoking. , 1990, Journal of the National Cancer Institute.

[22]  M. V. Reddy,et al.  Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. , 1986, Carcinogenesis.

[23]  H. Bartsch,et al.  The determination of urinary 3-methyladenine by immunoaffinity chromatography-monoclonal antibody-based ELISA: use in human biomonitoring studies. , 1990, Carcinogenesis.

[24]  C. Harris,et al.  Synchronous fluorescence spectroscopic, immunoaffinity chromatographic and 32P-postlabeling analysis of human placental DNA known to contain benzo[a]pyrene diol epoxide adducts. , 1990, Carcinogenesis.

[25]  S. Vedal,et al.  DNA adducts in bronchial biopsies , 1991, International journal of cancer.

[26]  V. L. Wilson,et al.  Alkyl and aryl carcinogen adducts detected in human peripheral lung. , 1989, Carcinogenesis.

[27]  J. Groopman,et al.  Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C. Harris,et al.  Detection of benzo(a)pyrene:DNA adducts in human white blood cells. , 1985, Cancer research.

[29]  N. Rothman,et al.  Formation of polycyclic aromatic hydrocarbon-DNA adducts in peripheral white blood cells during consumption of charcoal-broiled beef. , 1990, Carcinogenesis.

[30]  P. Vineis,et al.  Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity. , 1991, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[31]  M. Tockman,et al.  Biological monitoring of fire fighters: sister chromatid exchange and polycyclic aromatic hydrocarbon-DNA adducts in peripheral blood cells. , 1989, Cancer research.

[32]  K. Randerath,et al.  Tissue distribution of covalent DNA damage in mice treated dermally with cigarette 'tar': preference for lung and heart DNA. , 1988, Carcinogenesis.

[33]  C. Harris,et al.  Detection of benzo[a]pyrene diol epoxide-DNA adducts in human placenta. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[34]  L. Hsieh,et al.  Immunological detection of aflatoxin B1-DNA adducts formed in vivo. , 1988, Cancer research.

[35]  G. Lucier,et al.  Multiple DNA adducts in lymphocytes of smokers and nonsmokers determined by 32P-postlabeling analysis. , 1990, Carcinogenesis.

[36]  S. Hecht,et al.  Evaluation of 32P-postlabeling analysis of DNA from exfoliated oral mucosa cells as a means of monitoring exposure of the oral cavity to genotoxic agents. , 1989, Carcinogenesis.

[37]  I. Sarosi,et al.  Aflatoxin B1 formamidopyrimidine adducts in human hepatocarcinogenesis: a preliminary report. , 1989, Gastroenterology.

[38]  F. Perera,et al.  Postlabeling and immunoassay analysis of polycyclic aromatic hydrocarbons--adducts of deoxyribonucleic acid in white blood cells of foundry workers. , 1990, Scandinavian journal of work, environment & health.

[39]  K. Hemminki,et al.  Measurement by 32P-postlabelling of 7-methylguanine levels in white blood cell DNA of healthy individuals and cancer patients treated with dacarbazine and procarbazine. Human data and method development for 7-alkylguanines. , 1991, Carcinogenesis.

[40]  D. Shuker,et al.  Isolation of urinary 3-methyladenine using immunoaffinity columns prior to determination by low-resolution gas chromatography-mass spectrometry. , 1991, Chemical research in toxicology.

[41]  S. De Flora,et al.  Benzo[a]pyrene diolepoxide-DNA adducts in alveolar macrophages of smokers. , 1991, Carcinogenesis.

[42]  F. Perera The significance of DNA and protein adducts in human biomonitoring studies. , 1988, Mutation research.

[43]  M. Gould,et al.  32P-postlabeling analysis of DNA adducts in human and rat mammary epithelial cells. , 1988, Carcinogenesis.

[44]  S. Hecht,et al.  Detection of O6-methyldeoxyguanosine in human placental DNA. , 1988, Cancer research.

[45]  K. Hemminki,et al.  Monitoring occupational exposure to carcinogens: detection by 32P-postlabelling of aromatic DNA adducts in white blood cells from iron foundry workers. , 1988, Mutation research.

[46]  M. Schurdak,et al.  Postlabeling methods for carcinogen-DNA adduct analysis. , 1985, Environmental health perspectives.

[47]  M. Satoh,et al.  Immunoanalytical detection of O4-ethylthymine in liver DNA of individuals with or without malignant tumors. , 1989, Cancer research.

[48]  H. Rüdiger,et al.  32P-postlabelling analysis of DNA adducts in monocytes of smokers and passive smokers , 1990, International archives of occupational and environmental health.

[49]  D. Phillips,et al.  Aromatic DNA adducts in human bone marrow and peripheral blood leukocytes. , 1986, Carcinogenesis.

[50]  H. Stich,et al.  32P-postlabelling analysis of aromatic DNA adducts in human oral mucosal cells. , 1986, Carcinogenesis.

[51]  F. Perera,et al.  DNA adducts, protein adducts, and sister chromatid exchange in cigarette smokers and nonsmokers. , 1987, Journal of the National Cancer Institute.

[52]  C. Harris,et al.  Detection of benzo[a]pyrene diol epoxide-DNA adducts in peripheral blood lymphocytes and antibodies to the adducts in serum from coke oven workers. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[53]  P. Farmer,et al.  The determination of urinary 3-methyladenine in humans as a potential monitor of exposure to methylating agents. , 1987, Carcinogenesis.

[54]  R. C. Garner,et al.  Correlation of DNA adduct levels in human lung with cigarette smoking , 1988, Nature.

[55]  E. Bowman,et al.  Fluorescence detection of benzo[a]pyrene--DNA adducts in human lung. , 1991, Carcinogenesis.

[56]  M. Rajewsky,et al.  Monoclonal antibodies for the specific detection of 3-alkyladenines in nucleic acids and body fluids. , 1990, Carcinogenesis.